DFF-332

N/A

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameDFF-332
Drug Alias NameDFF-332NVP-DFF-332
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEndothelial PAS domain-containing protein 1 inhibitors
TargetsEndothelial PAS domain-containing protein 1
Therapy Area/IndicationsCarcinoma, Renal Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaUnited StatesSingapore +[7] 
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharmaceuticals Corp
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Pharmaceuticals Corp
Inactive CompaniesNovartis Pharma Ag
Active IndicationsCarcinoma, Renal Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A